BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 12511587)

  • 1. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.
    Casanova ML; Blázquez C; Martínez-Palacio J; Villanueva C; Fernández-Aceñero MJ; Huffman JW; Jorcano JL; Guzmán M
    J Clin Invest; 2003 Jan; 111(1):43-50. PubMed ID: 12511587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.
    Sánchez C; de Ceballos ML; Gomez del Pulgar T; Rueda D; Corbacho C; Velasco G; Galve-Roperh I; Huffman JW; Ramón y Cajal S; Guzmán M
    Cancer Res; 2001 Aug; 61(15):5784-9. PubMed ID: 11479216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor angiogenesis by cannabinoids.
    Blázquez C; Casanova ML; Planas A; Gómez Del Pulgar T; Villanueva C; Fernández-Aceñero MJ; Aragonés J; Huffman JW; Jorcano JL; Guzmán M
    FASEB J; 2003 Mar; 17(3):529-31. PubMed ID: 12514108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
    Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
    Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis.
    Larcher F; Franco M; Bolontrade M; Rodriguez-Puebla M; Casanova L; Navarro M; Yancopoulos G; Jorcano JL; Conti CJ
    Mol Carcinog; 2003 Jun; 37(2):83-90. PubMed ID: 12766907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice.
    Kedar D; Baker CH; Killion JJ; Dinney CP; Fidler IJ
    Clin Cancer Res; 2002 Nov; 8(11):3592-600. PubMed ID: 12429651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
    Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
    Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
    von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S
    J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of established tumors and metastases by potent vascular endothelial growth factor blockade.
    Huang J; Frischer JS; Serur A; Kadenhe A; Yokoi A; McCrudden KW; New T; O'Toole K; Zabski S; Rudge JS; Holash J; Yancopoulos GD; Yamashiro DJ; Kandel JJ
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7785-90. PubMed ID: 12805568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes.
    Wiley JL; Martin BR
    Chem Phys Lipids; 2002 Dec; 121(1-2):57-63. PubMed ID: 12505690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin.
    Sarlos S; Rizkalla B; Moravski CJ; Cao Z; Cooper ME; Wilkinson-Berka JL
    Am J Pathol; 2003 Sep; 163(3):879-87. PubMed ID: 12937129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors.
    Lambert DM; DiPaolo FG; Sonveaux P; Kanyonyo M; Govaerts SJ; Hermans E; Bueb J; Delzenne NM; Tschirhart EJ
    Biochim Biophys Acta; 1999 Sep; 1440(2-3):266-74. PubMed ID: 10521710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia.
    Hayashi T; Noshita N; Sugawara T; Chan PH
    J Cereb Blood Flow Metab; 2003 Feb; 23(2):166-80. PubMed ID: 12571448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
    Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
    Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.
    Ihenetu K; Molleman A; Parsons ME; Whelan CJ
    Eur J Pharmacol; 2003 Jan; 458(1-2):207-15. PubMed ID: 12498928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury.
    Widenfalk J; Lipson A; Jubran M; Hofstetter C; Ebendal T; Cao Y; Olson L
    Neuroscience; 2003; 120(4):951-60. PubMed ID: 12927201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical cannabinoid antinociception: synergy with spinal sites.
    Dogrul A; Gul H; Akar A; Yildiz O; Bilgin F; Guzeldemir E
    Pain; 2003 Sep; 105(1-2):11-6. PubMed ID: 14499415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the effect of cannabinoids on GABAergic neurotransmission in the substantia nigra pars reticulata.
    Wallmichrath I; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):326-34. PubMed ID: 11919658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.